These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 652378)

  • 1. Studies on purification of antibodies against tumor-specific antigens.
    Park MM
    Pahlavi Med J; 1978 Jan; 9(1):1-26. PubMed ID: 652378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization of neuroblastoma in vivo with tumor-specific antibodies.
    Terman DS; Stewart I; Tavel A; Kirch D
    Cancer Res; 1975 Jul; 35(7):1761-6. PubMed ID: 1093675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro demonstration of complement-dependent cytotoxic antibodies to Moloney sarcoma cells.
    Tamerius JD; Hellström I
    J Immunol; 1974 Jun; 112(6):1987-96. PubMed ID: 4825783
    [No Abstract]   [Full Text] [Related]  

  • 4. An in vitro immuno-enzymatic assay of tumor antigens in the mouse with beta-galactosidase.
    Celada F; Natali PG; Radojkovic J
    J Immunol; 1976 Sep; 117(3):904-10. PubMed ID: 784874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative detection of cytotoxic antibodies against tumor-specific antigens of murine sarcomas induced by 3-methylcholanthrene.
    Bloom ET
    J Natl Cancer Inst; 1970 Sep; 45(3):443-53. PubMed ID: 5523193
    [No Abstract]   [Full Text] [Related]  

  • 6. H-2 antigens and tumour-associated transplantation antigens in clones derived from a methylcholanthrene-induced BALB/c tumour: their influence on the generation in vitro and in vivo of the specific anti-tumour immune response.
    Pérez M; Garrido A; Algarra I; Caballero A; Delgado C; Collado MD; Fernández-Cruz E; Garrido F
    Exp Clin Immunogenet; 1989; 6(3):204-18. PubMed ID: 2631798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunochemical evidence of a tumor-specific surface antigen obtained by detergent solubilization of the membranes of a chemically induced sarcoma, meth-A.
    Natori T; Law LW; Appella E
    Cancer Res; 1978 Feb; 38(2):359-64. PubMed ID: 340027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of effective immunity to Moloney murine sarcoma virus using monoclonal anti-idiotypic antibody as immunogen.
    Powell TJ; Spann R; Nguyenduc M; Lamon EW
    J Immunol; 1989 Feb; 142(4):1318-24. PubMed ID: 2536772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosensitivity and histocompatibility antigens in drug-altered leukemic cells.
    Nicolin A; Franco P; Testorelli C; Goldin A
    Cancer Res; 1976 Jan; 36(1):222-7. PubMed ID: 1248001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Selective inactivation of specific T-suppressors immune to H-2 complex antigens and prevention of their generation in vivo by antisuppressor xenogenic antibodies].
    Abronina IF; Brondz BD; Suslov AP; Zaitseva MB; Karaulov AV
    Mol Biol (Mosk); 1981; 15(5):1131-43. PubMed ID: 6457978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and properties of an antiplasma cell serum directed against a defined plasmacytoma cell population.
    Proctor ML; Herscowitz HB
    J Immunol; 1975 Dec; 115(6):1642-9. PubMed ID: 1184969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of a differentiable antigen of activated T- and B-lymphocytes (AKA-1) in tumor cells].
    Nesterenko VG; Ermakov GP
    Biull Eksp Biol Med; 1982 Jul; 94(7):67-9. PubMed ID: 6982080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of short-term culture on the sensitivity of MDAY murine tumor cells tolysis mediated by normal rabbit serum.
    Caspi R; Witz IP
    Eur J Immunol; 1976 Mar; 6(3):174-9. PubMed ID: 1033065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping of SJL/J reticulum cell sarcoma tumor-associated Ia antigens by T cell hybridomas: characterization of tumor-specific and shared epitopes detected on IE+ allogeneic cells.
    Ohnishi K; Bonavida B
    J Immunol; 1986 Jul; 137(2):733-40. PubMed ID: 2424977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of tumor-associated antigens on ultraviolet light-induced tumors using antitumor antibodies developed in ascites fluid.
    Fortner GW; Takemoto LJ; Shehi L; Hansen JS
    Cancer Res; 1982 Jun; 42(6):2371-4. PubMed ID: 7042083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased sensitivity of murine leukemia virus-infected tumor cells to lymphocyte-mediated cytotoxicity.
    Kasai M; Yamaguchi H; Hosokawa M; Mizushima Y; Kobayashi H
    J Natl Cancer Inst; 1981 Aug; 67(2):417-22. PubMed ID: 6267345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-associated blocking factors: isolation from sera of tumor-bearing mice.
    Tamerius J; Nepom J; Hellström I; Hellström KE
    J Immunol; 1976 Mar; 116(3):724-30. PubMed ID: 1254951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody production and interaction with lymphoid cells in relation to tumor immunity in the Moloney sarcoma virus system.
    Harada M; Pearson G; Redmon L; Winters E; Kasuga S
    J Immunol; 1975 Apr; 114(4):1318-22. PubMed ID: 1090675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demonstration of natural antibodies in normal rabbit serum with similar specificity pattern as mouse natural killer cells.
    Grönberg A; Hansson M; Kiessling R; Andersson B; Kärre K; Roder J
    J Natl Cancer Inst; 1980 May; 64(5):1113-9. PubMed ID: 6966004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigens on human tumor cells assayed by complement fixation with allogeneic sera.
    Gupta RK; Irie RF; Morton DL
    Cancer Res; 1978 Aug; 38(8):2573-80. PubMed ID: 78763
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.